<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Temozolomide is an effective <z:chebi fb="0" ids="22333">alkylating agent</z:chebi> that is increasingly used for the treatment of pediatric <z:mp ids='MP_0009277'>brain tumors</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Secondary, or treatment-related, <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> is a life-threatening complication of alkylating chemotherapy and has been reported in children with <z:mp ids='MP_0009277'>brain tumors</z:mp> after treatments other than temozolomide </plain></SENT>
<SENT sid="2" pm="."><plain>We describe for the first time a case of temozolomide-related <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> in a child </plain></SENT>
</text></document>